Clinical Trial Update: TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma [NA]

View source ↗

Summary

A clinical trial from Fudan University is evaluating TPF-based concurrent chemoradiotherapy with immunotherapy for locally advanced esophageal squamous cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• TPF-based concurrent chemoradiotherapy with immunotherapy

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING